NCT00477152 - Study of Subcutaneous Rehydration With Recombinant Human Hyaluronidase for Infants and Children | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions

Dehydration

Interventions

DRUG

hyaluronidase (human recombinant)/rehydration fluid

Single 150 U subcutaneous (SC) HYLENEX dose administered immediately prior to start of SC infusion of rehydration fluid. Additional 150 U HYLENEX dose to be administered prior to any additional fluid infusion beyond 24 hours.